Benlysta 120 mg (Belimumab POWDER FOR SOLUTION) 120 MG

Benlysta 120 mg is a powder for solution used for intravenous administration. It contains belimumab, a monoclonal antibody indicated for specific autoimmune conditions. This medication is manufactured by GlaxoSmithKline Inc. in Canada.

Strength

120 MG

Pack Size

5ML

Manufacturer / TM Owner

GLAXOSMITHKLINE INC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Benlysta 120 mg is primarily used in the treatment of certain autoimmune diseases. It works by targeting specific cells in the immune system to help reduce inflammation and disease activity. Patients often wonder, 'What is Benlysta used for?' This medication is typically prescribed for conditions where the immune system attacks healthy tissues.

Side Effects

Common effects of Benlysta 120 mg may include infusion reactions, such as fever, nausea, and headache. Some patients may also experience fatigue or muscle pain. These effects are generally mild and temporary, but severe reactions are possible and should be reported to a healthcare provider immediately.

Precautions & Warnings

Benlysta 120 mg should be administered under the supervision of a healthcare professional. It is important to inform your doctor about any allergies or existing medical conditions before starting treatment. Patients should also be monitored for signs of infection, as this medication can affect the immune system.

Avoid Interactions

Benlysta 120 mg may interact with other medications, including those that suppress the immune system. It is important to discuss all current medications with a healthcare provider to avoid potential interactions. Alcohol and certain over-the-counter drugs should also be used with caution.

Frequently Asked Questions

Benlysta 120 mg is used to treat certain autoimmune diseases by targeting specific cells in the immune system.

Benlysta 120 mg is administered intravenously as a powder for solution.

Common side effects may include fever, nausea, headache, fatigue, and muscle pain.

It is important to discuss all current medications with a healthcare provider to avoid potential interactions.

Benlysta 120 mg is manufactured by GlaxoSmithKline Inc. in Canada.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.